Home HIV FAQ My Amedeo About Flying Publisher   

Amedeo Prize 2008
The 21 Finalists


  Gastric Cancer

  Free Subscription


Articles published in Anticancer Res

Retrieve available abstracts of 61 articles:
HTML format



Single Articles


    January 2008
  1. YAMASHITA K , Ooki A, Sakuramoto S, Kikuchi S, et al
    Lymph node metastasis density (ND)-factor association with malignant degree and ND40 as "non-curative factor" in gastric cancer.
    Anticancer Res. 2008;28.
    PubMed     Related articles    Abstract available


  2. KOBAYASHI K , Shida A, Yamada H, Ishibashi Y, et al
    Frequent splicing aberration of the base excision repair gene hMYH in human gastric cancer.
    Anticancer Res. 2008;28.
    PubMed     Related articles    Abstract available


  3. HSU PI , Lu PJ, Wang EM, Ger LP, et al
    Polymorphisms of death pathway genes FAS and FASL and risk of premalignant gastric lesions.
    Anticancer Res. 2008;28.
    PubMed     Related articles    Abstract available


    November 2007
  4. NESI G , Bruno L, Saieva C, Caldini A, et al
    DNA ploidy and S-phase fraction as prognostic factors in surgically resected gastric carcinoma: a 7-year prospective study.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


  5. YAMASHITA K , Sakuramoto S, Kikuchi S, Katada N, et al
    Surgical resection of stage IV gastric cancer and prognosis.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


  6. KATSUBE T , Kikuchi T, Konnno S, Murayama M, et al
    Subdural hematoma associated with dural metastasis of gastric carcinoma: report of two cases.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


  7. HOU L , Grillo P, Zhu ZZ, Lissowska J, et al
    COX1 and COX2 polymorphisms and gastric cancer risk in a Polish population.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


  8. RUBIO CA , Petersson F, Hoog A, Jonasson JG, et al
    Further studies on serrated neoplasias of the cardia: a review and case report.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


    September 2007
  9. YAMAGUCHI K , Nakagawa S, Yabusaki H, Nashimoto A, et al
    Combination chemotherapy with 5-fluorouracil, cisplatin and paclitaxel for pretreated patients with advanced gastric cancer.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


  10. CHANG HJ , Kim MH, Baek MK, Park JS, et al
    Triptolide inhibits tumor promoter-induced uPAR expression via blocking NF-kappaB signaling in human gastric AGS cells.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


    July 2007
  11. JIANG CG , Li JB, Liu FR, Wu T, et al
    Andrographolide inhibits the adhesion of gastric cancer cells to endothelial cells by blocking E-selectin expression.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


  12. MONIG SP , Nolden B, Lubke T, Pohl A, et al
    Clinical significance of nm23 gene expression in gastric cancer.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


  13. SKARLOS DV , Bai M, Goussia A, Samantas E, et al
    Expression of a molecular marker panel as a prognostic tool in gastric cancer patients treated postoperatively with docetaxel and irinotecan. A study of the Hellenic Cooperative Oncology Group.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


  14. OHASHI N , Nakanishi H, Kodera Y, Ito S, et al
    Intraoperative quantitative detection of CEA mRNA in the peritoneal lavage of gastric cancer patients with transcription reverse-transcription concerted (TRC) method. A comparative study with real-time quantitative RT-PCR.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


  15. SAI S , Ichikawa D, Tomita H, Ikoma D, et al
    Quantification of plasma cell-free DNA in patients with gastric cancer.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


  16. KODERA Y , Ito S, Mochizuki Y, Fujitake S, et al
    A phase II study of weekly paclitaxel as second-line chemotherapy for advanced gastric Cancer (CCOG0302 study).
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


  17. OZAKI T , Tamura K, Satoh T, Kurata T, et al
    Phase I study of combination therapy with S-1 and weekly docetaxel for advanced gastric cancer.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


    March 2007
  18. TANI N , Ichikawa D, Ikoma D, Tomita H, et al
    Circulating cell-free mRNA in plasma as a tumor marker for patients with primary and recurrent gastric cancer.
    Anticancer Res. 2007;27:1207-12.
    PubMed     Related articles    Abstract available


  19. CHANG MS , Lee HS, Jung EJ, Kim CW, et al
    Role and prognostic significance of proapoptotic proteins in Epstein-Barr virus-infected gastric carcinomas.
    Anticancer Res. 2007;27:785-91.
    PubMed     Related articles    Abstract available


    January 2007
  20. AKAIKE H , Kono K, Sugai H, Takahashi A, et al
    Expression of high mobility group box chromosomal protein-1 (HMGB-1) in gastric cancer.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


  21. CARUSO RA , Fedele F, Zuccala V, Fracassi MG, et al
    Mast cell and eosinophil interaction in gastric carcinomas: ultrastructural observations.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


  22. RHO M , Kim J, Jee CD, Lee YM, et al
    Expression of type 2 hexokinase and mitochondria-related genes in gastric carcinoma tissues and cell lines.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


  23. PITUCH-NOWOROLSKA A , Kolodziejczyk P, Kulig J, Drabik G, et al
    Circulating tumour cells and survival of patients with gastric cancer.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


  24. WACHOWIAK R , Kaifi JT, Schurr PG, Merkert P, et al
    Similar patterns of loss of heterozygosity in serum of adenocarcinoma of the distal oesophagus and the cardia in early diagnosis.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


  25. POHLEN U , Rieger H, Kunick-Pohlen S, Berger G, et al
    Phase II study of regional chemotherapy using the hypoxic abdominal perfusion technique in advanced abdominal carcinoma. 5-FU pharmacokinetics, complications and outcome.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


    November 2006
  26. KAWAMURA K , Takiguchi N, Wada A, Takenobu H, et al
    Up-regulated expression of the uridine phosphorylase gene in human gastric tumors is correlated with a favorable prognosis.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  27. KIKUCHI S , Futawatari N, Sakuramoto S, Watanabe M, et al
    Pre-operative tumor assessment of patients with gastric cancer based on virtual endoscopy using multidetector-row computer tomography.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  28. SHIBAGUCHI H , Luo NX, Kuroki M, Zhao J, et al
    A fully human chimeric immune receptor for retargeting T-cells to CEA-expressing tumor cells.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  29. OHASHI K , Kiura K, Takigawa N, Mizushima T, et al
    Successful treatment of a patient with gastric and duodenal metastases from large cell carcinoma of the lung with carboplatin and gemcitabine.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


    September 2006
  30. ZHENG H , Takahashi H, Murai Y, Cui Z, et al
    Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  31. MAMMANO E , Belluco C, Sciro M, Mencarelli R, et al
    Epidermal growth factor receptor (EGFR): mutational and protein expression analysis in gastric cancer.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  32. LIAKAKOS T , Troupis T, Ghiconti I, Triantafyllidis S, et al
    Immunohistochemical localization of thymidine phosphorylase in gastric cancer: is there a role of the differential expression in tumor cells and associated stromal cells?
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  33. YOSHIKAWA T , Tsuburaya A, Miyagi Y, Sekiguchi H, et al
    Up-regulation of hypoxia-inducible factor-1 alpha and VEGF mRNAs in peritoneal dissemination of patients with gastric cancer.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  34. KOIZUMI W , Tanabe S, Higuchi K, Sasaki T, et al
    Optimal dose-finding study of bi-weekly paclitaxel in unresectable advanced or recurrent gastric cancer.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  35. POLYZOS A , Tsavaris N, Kosmas C, Polyzos K, et al
    Subsets of patients with advanced gastric cancer responding to second-line chemotherapy with docetaxel-cisplatin.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  36. TONERI M , Mitsumoto Y, Shimabukuro M, Sunagawa T, et al
    Prognosis of patients with gastric carcinoma treated in remote island hospitals in Japan: a multivariable analysis.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  37. WATANABE M , Akiyama N, Sekine H, Mori M, et al
    Inhibition of poly (ADP-ribose) polymerase as a protective effect of nicaraven in ionizing radiation- and ara-C-induced cell death.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  38. HAKOZAKI M , Hojo H, Sato M, Tajino T, et al
    Establishment and characterization of a new cell line, FPS-1, derived from human undifferentiated pleomorphic sarcoma, overexpressing epidermal growth factor receptor and cyclooxygenase-2.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  39. NAKAYAMA Y , Matsumoto K, Inoue Y, Katsuki T, et al
    Correlation between the urinary dihydrouracil-uracil ratio and the 5-FU plasma concentration in patients treated with oral 5-FU analogs.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  40. HIRONAKA K , Yamaguchi Y, Okita R, Okawaki M, et al
    Essential requirement of toll-like receptor 4 expression on CD11c+ cells for locoregional immunotherapy of malignant ascites using a streptococcal preparation OK-432.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


    July 2006
  41. KASHIMA K , Nanashima A, Yasutake T, Sawai T, et al
    Decrease of telomeres and increase of interstitial telomeric sites in chromosomes of short-term cultured gastric carcinoma cells detected by fluorescence in situ hybridization.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  42. BARTSCH R , Woehrer S, Raderer M, Hejna M, et al
    Serum interleukin-6 levels in patients with gastric MALT lymphoma compared to gastric and pancreatic cancer.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  43. BURBANO RR , Assumpcao PP, Leal MF, Calcagno DQ, et al
    C-MYC locus amplification as metastasis predictor in intestinal-type gastric adenocarcinomas: CGH study in Brazil.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


    May 2006
  44. NAKAMURA Y , Shimada N, Suzuki T, Imatani A, et al
    In situ androgen production in human gastric carcinoma--androgen synthesizing and metabolizing enzymes.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  45. TENG XJ , Shen ZX, Xiang JJ, Shen L, et al
    Pre- and post-operative plasma big endothelin-1 levels in patients with gastric carcinoma undergoing radical gastrectomy.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  46. ISHIGAMI S , Natsugoe S, Miyazono F, Nakajo A, et al
    HLA-G expression in gastric cancer.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  47. IKOMA H , Ichikawa D, Koike H, Ikoma D, et al
    Correlation between serum DNA methylation and prognosis in gastric cancer patients.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  48. JIANG J , Xu N, Wu C, Deng H, et al
    Treatment of advanced gastric cancer by chemotherapy combined with autologous cytokine-induced killer cells.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  49. MORIOKA Y , Hibi K, Sakai M, Koike M, et al
    Aberrant methylation of the CHFR gene in digestive tract cancer.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


    March 2006
  50. TAKAHASHI T , Saikawa Y, Yoshida M, Kitagawa Y, et al
    A pilot study of combination chemotherapy with S-1 and low-dose cisplatin for highly advanced gastric cancer.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  51. IWASE H , Shimada M, Tsuzuki T, Okeya M, et al
    A phase I study of S-1 administration and a 24-h infusion of cisplatin plus paclitaxel in patients with advanced gastric cancer.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  52. YOSHIDA T , Yoshikawa T, Tsuburaya A, Kobayashi O, et al
    Feasibility study of biweekly CPT-11 plus CDDP for S-1- and paclitaxel-refractory, metastatic gastric cancer.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  53. RINO Y , Takanashi Y, Yukawa N, Saeki H, et al
    A phase I study of bi-weekly combination therapy with S-1 and docetaxel for advanced or recurrent gastric cancer.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  54. NAKAMURA R , Saikawa Y, Kubota T, Kumagai A, et al
    Role of the MTT chemosensitivity test in the prognosis of gastric cancer patients after postoperative adjuvant chemotherapy.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  55. OJIMA H , Araki K, Kato T, Okamura K, et al
    Clinicopathological characteristics and outcome indicators of stage II gastric cancer according to the Japanese classification of gastric cancer.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  56. OKADA K , Shimura T, Suehiro T, Mochiki E, et al
    Reduced galectin-3 expression is an indicator of unfavorable prognosis in gastric cancer.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  57. OJIMA H , Saito K, Yamauchi H, Yamaki E, et al
    P16 protein abnormality in Epstein-Barr virus-associated gastric carcinomas.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  58. WU CW , Chen JH, Kao HL, Li AF, et al
    PTPN3 and PTPN4 tyrosine phosphatase expression in human gastric adenocarcinoma.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  59. AYA M , Yashiro M, Nishioka N, Onoda N, et al
    Carcinogenesis in the remnant stomach following distal gastrectomy with billroth II reconstruction is associated with high-level microsatellite instability.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  60. AJIKI T , Hirata K, Okazaki T, Horiuchi H, et al
    Thymidylate synthase and dihydropyrimidine dehydrogenase expressions in gallbladder cancer.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


    January 2006
  61. KUNISAKI C , Akiyama H, Nomura M, Matsuda G, et al
    Clinicopathological properties of poorly-differentiated adenocarcinoma of the stomach: comparison of solid- and non-solid-types.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Bernd Sebastian Kamps website.

   Design: